跳至主要内容
临床试验/TCTR20160726002
TCTR20160726002已完成2 期

Procalcitonin-guided Discontinuation of Antibiotic in Ventilator-Associated Pneumonia

-0 个研究点目标入组 50 人开始时间: 2016年7月26日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 100 Years(—)
性别
All

入选标准

  • - Patients who were intubated and had received mechanical ventilation for at least 48 hours.
  • -age > 18 years
  • - clinical suspicion of VAP as defined by the ATS guidelines (new or progress pulmonary infiltration on CXR with two or more of the following: new or progress of fever; purulent sputum; WBC < 4,000 or > 12,000 cell/mm3); and simplified version of clinical pulmonary infection score > 6.

排除标准

  • - pregnant
  • - enrolled in another trial
  • - had little chance of survival
  • - had neutropenia (leukocyte counts <1000/µL or neutrophils <500/µL)
  • - had received immunosuppressants or long term corticosteroid therapy (≥ 0.5 mg/kg/day of prednisolone or equivalent dose for >1 month)
  • - had concomitant acquired immunodeficiency syndrome
  • - had a concomitant extrapulmonary infection diagnosed between days 1 and 3 that required prolonged (>8 days) antibiotic treatment or infection caused by confirmed non-bacterial pathogens such as fungus or virus.
  • - not received appropriate antibiotic within 3 days after enrollment
  • - had unfavorable clinical response after 7 days of appropriate antibiotic treatment as defined by one of the following: body temperature >37.8°C; shock or use of inotropes or vasopressors; clinical pulmonary infection score >6.

研究者

发起方
&#45;

相似试验